Magnesium sulfate in obstetrics: Current data;Le sulfate de magnésium en obstétrique: Données actuelles

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 33, Issue 6 I, 2004, Pages 510-517

  Azria, E ^a   Tsatsaris, V ^a   Goffinet, F ^a   Kayem, G ^a   Mignon, A ^a   Cabrol, D ^a  

^a Paris V ^*  (France)

Author keywords

Eclampsia; Magnesium sulfate; Preeclampsia; Pregnancy; Tocolytic

Indexed keywords

MAGNESIUM SULFATE;

BRAIN PROTECTION; CLINICAL TRIAL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; ECLAMPSIA; FEMALE; HUMAN; META ANALYSIS; PREECLAMPSIA; PREGNANCY; REVIEW; TOCOLYSIS;

EID: 5644235135     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0368-2315(04)96564-7     Document Type: Review

References (42)

1. Besinger RE, Niebyl JR. The safety and efficacy of tocolytic agents for the treatment of preterm labor. Obstet Gynecol Surv 1990; 45: 415-40.
2. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002; 359: 1877-90.
3. Mittendorf R, Covert R, Boman J, Khoshnood B, Lee KS, Siegler M. Is tocolytic magnesium sulphate associated with increased total paediatric mortality? Lancet 1997; 350: 1517-8.
4. Mittendorf R, Covert R, Elin R, Pryde PG, Khoshnood B, Lee K. Umbilical cord serum ionized magnesium level and total pediatric mortality. Obstet Gynecol 2001; 98: 75-8.
5. Mittendorf R, Dambrosia J, Pryde PG, Lee KS, Gianopoulos JG, Besinger RE, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002; 186: 1111-8.
6. Gordon MC, Iams JD. Magnesium sulfate. Clin Obstet Gynecol 1995; 38: 706-12.
7. Hall D, McGauthery H, Corey E, Thorton W. The effect of magnesium therapy on the duration of labour. Am J Obstet Gynecol 1954; 78: 27-32.
8. Taber EB, Tan L, Chao CR, Beall MH, Ross MG. Pharmacokinetics of ionized versus total magnesium in subjects with preterm labor and preeclampsia. Am J Obstet Gynecol 2002; 186: 1017-21.
9. Hallak M, Berry SM, Madincea F, Romero R, Evans MI, Cotton DB. Fetal serum and amniotic fluid magnesium concentrations with maternal treatment. Obstet Gynecol 1993; 81: 185-8.
10. Madden C, Owen J, Hauth JC. Magnesium tocolysis: serum levels versus success. Am J Obstet Gynecol 1990; 162: 1177-80.
11. Cox SM, Sherman ML, Leveno KJ. Randomized investigation of magnesium sulfate for prevention of preterm birth. Am J Obstet Gynecol 1990; 163: 767-72.
12. Larmon JE, Ross BS, May WL, Dickerson GA, Fischer RG, Morrison JC. Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor. Am J Obstet Gynecol 1999; 181: 1432-7.
13. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 2002:CD001060.
14. Rodts-Palenik S, Morrison JC. Tocolysis: an update for the practitioner. Obstet Gynecol Surv 2002; 57: S9-34.
15. Snyder SW, Cardwell MS. Neuromuscular blockade with magnesium sulfate and nifedipine. Am J Obstet Gynecol 1989; 161: 35-6.
16. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995; 95: 263-9.
17. Schendel DE, Berg CJ, Yeargin-Allsopp M, Boyle CA, Decoufle P. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. JAMA 1996; 276: 1805-10.
18. Benichou J, Zupan V, Fernandez H, Marpeau L, Marret S. Tocolytic magnesium sulphate and paediatric mortality. Lancet 1998; 351: 290-1.
19. Crowther CA, Hiller JE, Doyle LW, Haslam RR. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 2003; 290: 2669-76.
20. Belfort MA, Moise KJ, Jr. Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study. Am J Obstet Gynecol 1992; 167: 661-6.
21. Sadeh M. Action of magnesium sulfate in the treatment of preeclampsia-eclampsia. Stroke 1989; 20: 1273-5.
22. Goldman RS, Finkbeiner SM. Therapeutic use of magnesium sulfate in selected cases of cerebral ischemia and seizure. N Engl J Med 1988; 319: 1224-5.
23. Assaley J, Baron JM, Cibils LA. Effects of magnesium sulfate infusion upon clotting parameters in patients with pre-eclampsia. J Perinat Med 1998; 26: 115-9.
24. Yang Q, Liu YC, Zou W, Yim AP, He GW. Protective effect of magnesium on the endothelial function mediated by endothelium-derived hyperpolarizing factor in coronary arteries during cardioplegic arrest in a porcine model. J Thorac Cardiovasc Surg 2002; 124: 361-70.
25. Bussiere FI, Mazur A, Fauquert JL, Labbe A, Rayssiguier Y, Tridon A. High magnesium concentration in vitro decreases human leukocyte activation. Magnes Res 2002; 15: 43-8.
26. Vincent RD, Jr., Chestnut DH, Sipes SL, Weiner CP, DeBruyn CS, Bleuer SA. Magnesium sulfate decreases maternal blood pressure but not uterine blood flow during epidural anesthesia in gravid ewes. Anesthesiology 1991; 74: 77-82.
27. Lee MI, Todd HM, Bowe A. The effects of magnesium sulfate infusion on blood pressure and vascular responsiveness during pregnancy. Am J Obstet Gynecol 1984; 149: 705-8.
28. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 1455-63.
29. Sibai BM. Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. Am J Obstet Gynecol 1990; 762: 1141-5.
30. Dommisse J. Phenytoin and magnesium sulfate in eclampsia. Am J Obstet Gynecol 1990; 163: 1089-91.
31. Crowther C. Magnesium sulphate versus diazepam in the management of eclampsia: a randomized controlled trial. Br J Obstet Gynaecol 1990; 97: 110-7.
32. Duley L, Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev 2003:CD000128.
33. Duley L, Henderson-Smart D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev 2003:CD000127.
34. Haddad B. Prise en charge de la prééclampsie. In: CNGOF, ed. Mises à jour en Gynécologie et Obstétrique. Paris, 2001 (vol Tome XXV).
35. Coetzee EJ, Dommisse J, Anthony J. A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia. Br J Obstet Gynaecol 1998; 105: 300-3.
36. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333: 201-5.
37. Guidotti R. The magpie trial. Lancet 2002; 360: 1331; author reply 1331-2.
38. Sibai BM. The magpie trial. Lancet 2002; 360: 1329; author reply 1331-2.
39. Walters BN, Graham D, Hamilton D. The magpie trial. Lancet 2002; 360: 1329-30; author reply 1331-2.
40. Goffinet F, Aboulker D, Paris-Llado J, Bucourt M, Uzan M, Papiernik E et al. Screening with a uterine Doppler in low risk pregnant women followed by low dose aspirin in women with abnormal results: a multicenter randomised controlled trial. BJOG 2001; 108: 510-8.
41. Mittendorf R, Dambrosia J, Dammann O, Pryde PG, Lee KS, Ben-Ami TE et al. Association between maternal serum ionized magnesium levels at delivery and neonatal intraventricular hemorrhage. J Pediatr 2002; 140: 540-6.
42. Belfort MA, Anthony J, Saade GR, Allen JC, Jr. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 2003; 348: 304-11.